Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Borer

Showing results (71-80 of 394) with videos related to

Pageof 40
Sort By:
The Journal of International Medical Research|January 1, 1976
Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectorisJ S Borer, M B Comerford, E Sowton
Cardiology|May 27, 2009
Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectorisMichal Tendera, Jeffrey S Borer, Jean-Claude Tardif
Cardiology|August 31, 2013
Etiology of valvular heart disease in the 21st centuryKonstantinos Dean Boudoulas, Jeffrey S Borer, Harisios Boudoulas
Advances in Cardiology|June 14, 2002
The epidemiology of valvular heart disease: an emerging public health problemPhyllis G Supino, Jeffrey S Borer, Andrew Yin
European Heart Journal|July 30, 2013
Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failureLuigi Tavazzi, Aldo P Maggioni, Jeffrey S Borer
Cardiology|January 1, 1993
Myofibrillar protein turnover in cardiac hypertrophy due to aortic regurgitationN M Magid, D C Wallerson, J S Borer
JAMA|April 10, 2008
When should data and safety monitoring committees share interim results in cardiovascular trials?Jeffrey S Borer, David J Gordon, Nancy L Geller
Progress in Nuclear Medicine|January 1, 1980
Radionuclide cineangiography in the clinical assessment of patients with coronary and valvular heart diseasesJ S Borer, S L Bacharach, M V Green
Zeitschrift Fur Kardiologie|February 1, 1983
[Behavior of rest and stress ejection fraction in myocardial infarct patients before and after 4 weeks of training. Comparison with a control group]E Grodzinski, F Kreutz, G Blümchen, et al.
European Heart Journal|August 15, 2006
Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?Kim Fox, Roberto Ferrari, Salim Yusuf, et al.
Pageof 40

Showing results (71-80 of 394) with videos related to

Sort By:
Pageof 40
The Journal of International Medical Research|January 1, 1976
Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectorisJ S Borer, M B Comerford, E Sowton
Cardiology|May 27, 2009
Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectorisMichal Tendera, Jeffrey S Borer, Jean-Claude Tardif
Cardiology|August 31, 2013
Etiology of valvular heart disease in the 21st centuryKonstantinos Dean Boudoulas, Jeffrey S Borer, Harisios Boudoulas
Advances in Cardiology|June 14, 2002
The epidemiology of valvular heart disease: an emerging public health problemPhyllis G Supino, Jeffrey S Borer, Andrew Yin
European Heart Journal|July 30, 2013
Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failureLuigi Tavazzi, Aldo P Maggioni, Jeffrey S Borer
Cardiology|January 1, 1993
Myofibrillar protein turnover in cardiac hypertrophy due to aortic regurgitationN M Magid, D C Wallerson, J S Borer
JAMA|April 10, 2008
When should data and safety monitoring committees share interim results in cardiovascular trials?Jeffrey S Borer, David J Gordon, Nancy L Geller
Progress in Nuclear Medicine|January 1, 1980
Radionuclide cineangiography in the clinical assessment of patients with coronary and valvular heart diseasesJ S Borer, S L Bacharach, M V Green
Zeitschrift Fur Kardiologie|February 1, 1983
[Behavior of rest and stress ejection fraction in myocardial infarct patients before and after 4 weeks of training. Comparison with a control group]E Grodzinski, F Kreutz, G Blümchen, et al.
European Heart Journal|August 15, 2006
Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?Kim Fox, Roberto Ferrari, Salim Yusuf, et al.
Pageof 40